about
Successful treatment of mitomycin C-associated hemolytic uremic syndrome by plasmapheresisMyostatin mediates abdominal aortic atherosclerosis progression by inducing vascular smooth muscle cell dysfunction and monocyte recruitment.Acute effects of peritoneal dialysis with dialysates containing dextrose or dextrose and amino acids on muscle protein turnover in patients with chronic renal failure.Amino acid metabolism, substrate availability and the control of protein dynamics in the human kidney.Interorgan amino acid exchange.Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: Alfa-enolase and borderline antigens.The metabolic conversion of phenylalanine into tyrosine in the human kidney: does it have nutritional implications in renal patients?Uric acid promotes apoptosis in human proximal tubule cells by oxidative stress and the activation of NADPH oxidase NOX 4.Protein-energy wasting and mortality in chronic kidney disease.Muscle amino acid and protein metabolism in chronic renal failure.Gender and the progression of chronic renal diseases: does apoptosis make the difference?Causes of hyperhomocysteinemia in patients with chronic kidney diseases.Insulin sensitivity of muscle protein metabolism is altered in patients with chronic kidney disease and metabolic acidosis.Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency.Kidney, splanchnic, and leg protein turnover in humans. Insight from leucine and phenylalanine kinetics.Effects of recombinant human growth hormone on muscle protein turnover in malnourished hemodialysis patients.Effect of kidney failure and hemodialysis on protein and amino acid metabolism.What can we learn from a statistically inconclusive trial? Consensus conference on the EVOLVE study results.Autoimmune central diabetes insipidus in a patient with ureaplasma urealyticum infection and review on new triggers of immune response.Modulation of Myostatin/Hepatocyte Growth Factor Balance by Different Hemodialysis Modalities.De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients.Stat3 activation links a C/EBPδ to myostatin pathway to stimulate loss of muscle mass.Lysine triggers apoptosis through a NADPH oxidase-dependent mechanism in human renal tubular cells.Interorgan handling of fibroblast growth factor-23 in humans.Peripheral artery disease and blood pressure profile abnormalities in hemodialysis patients.Abnormalities in amino acid metabolism in patients with chronic renal failure. A pathophysiological approach to the nutritional treatment. I. Studies in the postabsorptive state.Androgen-mediated apoptosis of kidney tubule cells: role of c-Jun amino terminal kinase.Testosterone promotes apoptotic damage in human renal tubular cells.Renal ammoniagenesis in an early stage of metabolic acidosis in man.Taurine prevents apoptosis induced by high ambient glucose in human tubule renal cells.Regression of asymptomatic cardiomyopathy and clinical outcome of renal transplant recipients: a long-term prospective cohort study.Arteriovenous fistula of the native kidney: diagnosis by duplex Doppler ultrasound.Toll-like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney diseaseLow-protein diets for chronic kidney disease patients: the Italian experience.Studying Muscle Protein Turnover in CKDEffects of chronic metabolic acidosis on splanchnic protein turnover and oxygen consumption in human beings.Leptin as a uremic toxin interferes with neutrophil chemotaxis.Amino acid loss with polyethersulfone.Role of PKC-delta activity in glutathione-depleted neuroblastoma cells.A novel role of protein kinase C-delta in cell signaling triggered by glutathione depletion.
P50
Q28340661-171A70EC-96CA-46E1-9948-58A2F1CA9B5AQ30358722-161142C3-727B-4ABA-BABC-0FE72C42A3FCQ31961616-C5CE4F33-2D89-43E3-BA23-B2CD572CC98FQ33736463-3878C4DA-92D2-4A84-9337-77E296DCD3F9Q33821441-EC7E5869-B58D-4B8D-B145-C7146FBE6E50Q33922405-E6F0599F-6E61-483E-9535-513AE16AD829Q34514560-EF2880DE-C226-461D-A7F0-F6026DFA2145Q34713167-FC084977-6CC2-4320-ABFC-CC0E00EF0E44Q35024794-011D73EA-3B9D-41E0-9FE1-2B0757EBAC2FQ35664866-108F50B2-FC91-4EE6-8E63-27A2EADCDAE7Q35803792-6C91FD5C-8002-49CE-830E-57797E9A129CQ36368142-E43AD8B0-ACC0-4DE1-826E-4C0E1BA676A2Q36369287-0EAEE4C0-9D28-4F78-8953-D8A8623A8E70Q37022645-C9929771-2CC6-4904-B448-84FD6CCC1153Q37360036-23E78BE6-0672-41DF-8CB5-481A9288169BQ37362331-724F8E30-02E0-4F96-8F2F-AEC3B64A095CQ37959663-B06D47CB-2702-48AF-8D84-6E05EA5D642BQ38176813-704AC2D9-D3C0-4F75-8890-BC7F9DEE5443Q38578832-9DD30F15-5247-4BFB-B989-B635F898E497Q38811545-A4F801DC-0299-46B3-9873-612D98E2EFC3Q38861456-EB6D84ED-6505-4595-9B8A-DBC25BE6615CQ39099310-6D35B296-1D9A-48B6-8329-5ABCF2CB2E07Q39382915-5DF3D846-2CF7-4508-AC50-5E3A4A5D2DADQ39456034-F17840BC-90A3-4A1B-875E-16A099A656C0Q39718045-6AD5C78F-44CB-4F1D-B06F-CD7A7540EC10Q39761097-F595F333-2198-494D-9D4C-EB87EFCC378DQ39823732-5FB12B52-FD4C-4215-A18A-504A236A3B3EQ40566524-EF7AFE75-0B5C-4C29-8DD1-79E686F89C4AQ40685685-A0265A36-1F8F-4BB1-94EF-B20CB6E60C73Q40691127-6BF92D2F-26E2-4040-B069-78E110CEEBCEQ41211385-D3810B04-6F22-4A5E-A3EF-C661E377CB5DQ41953120-736E3FB2-2395-4D7A-A4FF-79CE6154866BQ42144013-00F4C8FC-11C8-43FC-9839-8DC206FB7E63Q42426578-7792947F-EE2A-4ED8-9602-D0B9DEBD27DBQ42430337-26D5C1B6-011B-4C25-A198-A986D0009B9FQ43212691-CDAF5A65-8689-4D3C-BB78-E4B5B1613876Q44065136-E8F89114-A4D5-453E-849C-99667951D7EDQ44236764-84827EF5-50B2-4322-AB0C-EBDD83F97A47Q44555295-6D376438-6F9A-4FE9-940A-EF34604610B9Q44614776-3BEA13C4-84AC-471E-8290-D1EE0BA91DDA
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Giacomo Garibotto
@ast
Giacomo Garibotto
@en
Giacomo Garibotto
@es
Giacomo Garibotto
@nl
Giacomo Garibotto
@sl
type
label
Giacomo Garibotto
@ast
Giacomo Garibotto
@en
Giacomo Garibotto
@es
Giacomo Garibotto
@nl
Giacomo Garibotto
@sl
prefLabel
Giacomo Garibotto
@ast
Giacomo Garibotto
@en
Giacomo Garibotto
@es
Giacomo Garibotto
@nl
Giacomo Garibotto
@sl
P106
P1153
7005350271
P21
P31
P496
0000-0001-6432-2429